Medical instruments and techniques for thermally-mediated therapies
A surgical instrument for thermally-mediated therapies in targeted tissue volumes and for causing thermal effects in polymer tissue-contacting members. In one embodiment, the instrument has a working end with an interior chamber that is supplied with a biocompatible liquid. An energy source causes a liquid-to-vapor phase change within the interior of the instrument. The vapor phase media then is ejected from the working surface of the instrument, and a controlled vapor-to-liquid phase change in an interface with tissue applies thermal energy substantially equal to the heat of vaporization to ablate tissue. The vapor-to-liquid phase transitions, or internal energy releases, can be provided about thin-film flexible structures for engaging body lumens and cavities. An exemplary embodiment can be used for shrinking, sealing, welding or creating lesions in tissue—while causing limited collateral thermal damage and while totally eliminating electrical current flow in the engaged tissue.
1. A method of delivering a condensable vapor to a uterus comprising:
expanding a flexible structure to engage tissue in an interior of the uterus;
delivering the condensable vapor into the flexible structure; and
releasing heat of vaporization to the uterus in a vapor-to-liquid transition of the condensable vapor.
2. The method of claim 1 wherein the heat of vaporization is in excess of about 500 calories per gram of the condensable vapor.
3. The method of claim 1 further comprising controlling a parameter of the class of parameters consisting of controlling a temperature of the vapor-to-liquid phase transition, controlling a pressure of the condensable vapor, controlling a volume of condensable vapor, and controlling a rate of delivery of the condensable vapor.
4. The method of claim 1 wherein the condensable vapor collapses in volume upon the vapor-to-liquid transition.
5. The method of claim 1 wherein the vapor-to-liquid transition applies thermal energy capable of modifying tissue.
6. The method of claim 1 wherein the vapor-to-liquid transition applies thermal energy capable of at least one of shrinking, sealing, welding and creating lesions in tissue.
7. The method of claim 1 wherein the condensable vapor has a temperature of at least 100° C.
8. The method of claim 1 wherein the flexible structure comprises a shape memory alloy.
9. The method of claim 1 wherein the flexible structure comprises a balloon.
10. A method of delivering a condensable vapor to a uterus comprising:
expanding a flexible structure to engage tissue in an interior of the uterus;
delivering the condensable vapor through the flexible structure; and
releasing heat of vaporization to the uterus in a vapor-to-liquid transition of the condensable vapor.
11. The method of claim 10 wherein the heat of vaporization is in excess of about 500 calories per gram of the condensable vapor.
12. The method of claim 10 further comprising controlling a parameter of the class of parameters consisting of controlling a temperature of the vapor-to-liquid phase transition, controlling a pressure of the condensable vapor, controlling a volume of condensable vapor, and controlling a rate of delivery of the condensable vapor.
13. The method of claim 10 wherein the condensable vapor collapses in volume upon the vapor-to-liquid transition.
14. The method of claim 10 wherein the vapor-to-liquid transition applies thermal energy capable of modifying tissue.
15. The method of claim 10 wherein the vapor-to-liquid transition applies thermal energy capable of at least one of shrinking, sealing, welding and creating lesions in tissue.
16. The method of claim 10 wherein the condensable vapor has a temperature of at least 100° C.
17. The method of claim 10 wherein the flexible structure comprises a shape memory alloy.
18. The method of claim 10 wherein the flexible structure comprises a balloon.